Interesting explanation by CNBC to the fact that all in a sudden beaten down (AMLN) is up about 4% in pre-market. According to CNBC "it would make perfect sense for Pfizer (PFE) to buy Amylin Pharmaceuticals Inc. (AMLN) and "acquire rights for their once a week diabetes drug".
Pfizer press release is soon to follow.
Could not be better timing - I, accidentally, bought some Mar30 calls on a cheap just few days ago.(AMLN) long idea was also posted on Member Site - Free Preview is still on - till Friday.
Wednesday, March 05, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment